| Autor: |
Cabrita R; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Lauss M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Sanna A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Skaarup Larsen M; Department of Clinical Pathology, Herlev University Hospital, Herlev, Denmark., Mitra S; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Johansson I; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Phung B; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Harbst K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Vallon-Christersson J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., van Schoiack A; NanoString Technologies, Seattle, WA, USA., Lövgren K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Warren S; NanoString Technologies, Seattle, WA, USA., Jirström K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Olsson H; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Pietras K; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University Cancer Center, Lund University, Lund, Sweden., Ingvar C; Department of Surgery, Skåne University Hospital, Lund, Sweden., Isaksson K; Department of Surgery, Skåne University Hospital, Lund, Sweden., Schadendorf D; Department of Dermatology, University Hospital of Essen, Essen, Germany., Schmidt H; Department of Oncology, Århus University Hospital, Aarhus, Denmark., Bastholt L; Department of Oncology, Odense University Hospital, Odense, Denmark., Carneiro A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.; Department of Oncology, Skåne University Hospital, Lund, Sweden., Wargo JA; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Jönsson G; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden. goran_b.jonsson@med.lu.se. |
Full text from SpringerLink